Acta Derm Venereol

1. METSINI A, Ryen L, Montgomery S, Molarius A, et al
   Relationship between Dermatology Life Quality Index Scores and EQ-5D-5L Utility Values in Adults with Atopic Dermatitis: Development of a Swedish Mapping Model.
   Acta Derm Venereol. 2026;106:0277.
   

   >> Share

   
   

   
   Allergy

2. NGUYEN TH, Akdis C, Baccarelli A, Banerjee S, et al
   Leveraging Artificial Intelligence in Allergy, Asthma, and Immunology With Environmental Exposures.
   Allergy. 2026 Jun 3. doi: 10.1111/all.70401.
   

   >> Share

   
   
3. TSUANG AJ, Chung SA, Lin AA, Baloh CH, et al
   Elevated Neonatal Electrical Impedance Spectroscopy Measurements Are Associated With Atopic Dermatitis in High-Risk Infants.
   Allergy. 2026 Jun 2. doi: 10.1111/all.70402.
   

   >> Share

   
   

   
   Ann Allergy Asthma Immunol

4. FINEMAN SM, Hernandez-Trujillo V, Joshi SR, Chow T, et al
   From the pages of AllergyWatch.
   Ann Allergy Asthma Immunol. 2026;136:729-730.
   

   >> Share

   
   
5. NOWAK-WEGRZYN A, Levi-Schaffer F
   Meaningful outcomes in food allergy immunotherapy: Measuring what counts.
   Ann Allergy Asthma Immunol. 2026;136:619-620.
   

   >> Share

   
   
6. DE BENEDETTO A, Boguniewicz M, Fonacier L, Silverberg J, et al
   Atopic dermatitis Yardstick: a new era of topical and systemic treatments.
   Ann Allergy Asthma Immunol. 2026 Jun 1:S1081-1206(26)00232.
   

   >> Share

   
   
7. JUNG M, Kyung Y, Kim M, Kim S, et al
   Neonatal urinary phthalate metabolite concentrations are associated with the development of atopic dermatitis.
   Ann Allergy Asthma Immunol. 2026 May 29:S1081-1206(26)00236.
   

   >> Share

   
   
8. GREIMANN E, Lin CH, Freigeh G, Nelson B, et al
   Treatment for Mild Asthma: What Matters to Providers.
   Ann Allergy Asthma Immunol. 2026 Mar 10:S1081-1206(26)00096.
   

   >> Share

   
   
9. BUCKEY TM, Frangiosa J, Diem L, Hanna E, et al
   Eosinophilic esophagitis incidence during single and multiple food oral immunotherapy.
   Ann Allergy Asthma Immunol. 2026;136:693-698.
   

   >> Share

   
   

   
   BMC Pediatr

10. HUANG S, Zhang Z, Zhang H, Qiu K, et al
    Early life factors and genetic interactions in allergic rhinitis: a genome-wide study.
    BMC Pediatr. 2026 May 30. doi: 10.1186/s12887-026-07052.
    

    >> Share

    
    

    
    BMJ

11. NADARAJAH S
    Peanut allergy in adults: how is treatment changing?
    BMJ. 2026;393:s748.
    

    >> Share

    
    

    
    Contact Dermatitis

12. NG KL, Tam MM, Nixon R
    Dupilumab Facial Redness Due to Allergic Contact Dermatitis and Malassezia Hypersensitivity: A Case Report.
    Contact Dermatitis. 2026 Jun 4. doi: 10.1111/cod.70196.
    

    >> Share

    
    

    
    Int Arch Allergy Immunol

13. ALRAFIAAH AS, Khalaf R, Sillcox C, Noorsaeed SM, et al
    Concomitant Chronic Urticaria in Children: A Distinct Severe Phenotype.
    Int Arch Allergy Immunol. 2026;187:599-604.
    

    >> Share

    
    
14. NACARKUCUK E, Eker I, Gursel O, Bagci S, et al
    Decreased mean platelet volume is associated with loss of asthma control and exacerbation in children with asthma.
    Int Arch Allergy Immunol. 2025 Aug 26:1-21. doi: 10.1159/000547893.
    

    >> Share

    
    
15. YEGIN KATRAN Z, Bulut I, Salman A
    Low Total IgE Predicts Non-Response to Omalizumab in Chronic Spontaneous Urticaria: A 10-Year Real-Life Study.
    Int Arch Allergy Immunol. 2026;187:605-615.
    

    >> Share

    
    
16. BURHAN M, Ashraf S, Ali A, Shahid I, et al
    Safety and Efficacy of Remibrutinib for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis.
    Int Arch Allergy Immunol. 2026;187:635-646.
    

    >> Share

    
    

    
    J Am Acad Dermatol

17. LULLO JJ
    JAAD Game Changers: "Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)".
    J Am Acad Dermatol. 2026 Jun 3:S0190-9622(26)02816.
    

    >> Share

    
    
18. LAKE E
    JAAD Game Changer of the Year: "Real-world treatment outcomes of systemic treatments for moderate-to-severe atopic dermatitis in children aged less than 12 years: 2-year results from PEDIatric STudy in Atopic Dermatitis".
    J Am Acad Dermatol. 2026 Jun 2:S0190-9622(26)02802.
    

    >> Share

    
    
19. EZZAT RZ, Paz M, Kreytak C, Senna MM, et al
    Major adverse cardiovascular events and venous thromboembolism in older adults aged 50 or older with atopic dermatitis treated with oral Janus kinase inhibitors: a multicenter cohort study using TriNetX.
    J Am Acad Dermatol. 2026 Jun 2:S0190-9622(26)02800.
    

    >> Share

    
    

    
    J Dermatol

20. TSUNEMI Y, Igarashi A, Ishido T, Saeki H, et al
    Real-World Maintenance of Remission in Atopic Dermatitis Patients With Upadacitinib: A Multicenter Retrospective Study in Japan (ROADMAP Study).
    J Dermatol. 2026 Jun 4. doi: 10.1111/1346-8138.70299.
    

    >> Share

    
    

    
    J Invest Dermatol

21. PETERS RHW, Smits JPH, van den Bogaard EH, Kelemen E, et al
    Advantages and limitations of in vitro models for atopic dermatitis: A consensus expert opinion.
    J Invest Dermatol. 2026 Jun 5:S0022-202X(26)01200.
    

    >> Share

    
    
22. YANG K, Mircescu A, Okusanya D, Mohsen S, et al
    Understanding the Atopic Dermatitis-Psoriasis Phenotypic Switch Through a Pharmacovigilance-Based Approach.
    J Invest Dermatol. 2026 Jun 1:S0022-202X(26)01267.
    

    >> Share

    
    

    
    Pediatr Dermatol

23. BUETHE MG, Sy T, Eichenfield LF
    Safety of Dupilumab and Risk of Cutaneous T-Cell Lymphoma in Pediatric Patients With Atopic Dermatitis: A Data-Driven Guide to Counseling Patients and Families.
    Pediatr Dermatol. 2026 May 31. doi: 10.1111/pde.70285.
    

    >> Share

    
    

    
    Pediatrics

24. YOUNG EE, Bullard-Elias D, Faul S, Luong J, et al
    Improving the Delivery of Quality Evidence-Based Inpatient Asthma Care.
    Pediatrics. 2026 May 8:e2025073834. doi: 10.1542/peds.2025-073834.
    

    >> Share

    
    

    
    PLoS Genet

25. ZHANG H, He K, Tsoi LC, Zhou X, et al
    mFABIO: An integrative multi-tissue TWAS fine-mapping approach to prioritize potentially causal genes and tissues underlying binary traits.
    PLoS Genet. 2026;22:e1012157.
    

    >> Share

    
    

    
    PLoS Med

26. SHAKHSHIR LA, Karain A, Pell JP, Hastie CE, et al
    Prenatal exposure to asthma medications and risk of neurodevelopmental disorders and educational difficulties: A systematic review and meta-analysis.
    PLoS Med. 2026;23:e1005100.
    

    >> Share

    
    

    
    PLoS One

27. CHEN X, Zhao L, Luo W
    Study on the pathogenesis of PLXNB1 gene in olfactory dysfunction of allergic rhinitis.
    PLoS One. 2026;21:e0350102.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share